139 results on '"Puozzo, C."'
Search Results
2. Metabolism pathway of vinorelbine (Navelbine ®) in human: Characterisation of the metabolites by HPLC–MS/MS
3. Exposure equivalence between IV (0.8 mg/kg) and oral (1 mg/kg) busulfan in adult patients
4. Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring
5. Evaluation of oral versus intravenous dose of vinorelbine to achieve equivalent blood exposures in patients with solid tumours
6. Intravenous busulfan in adults prior to haematopoietic stem cell transplantation: a population pharmacokinetic study
7. Development of a sensitive liquid chromatography method coupled with a tandem mass spectrometric detection for the clinical analysis of vinflunine and 4-O-deacetyl vinflunine in blood, urine and faeces
8. A high performance liquid chromatography method for vinorelbine and 4- O-deacetyl vinorelbine: A decade of routine analysis in human blood
9. I.V. busulfan in pediatrics: a novel dosing to improve safety/efficacy for hematopoietic progenitor cell transplantation recipients
10. Novel disease-specific behaviour of intravenous busulfan in children with thalassaemia undergoing haematopoietic stem cell transplantation requires a different approach to therapeutic drug monitoring: O395
11. Which bioequivalence study for a racemic drug? Application to milnacipran
12. Pharmacokinetics of milnacipran in renal impairment
13. Pharmacokinetics of milnacipran in liver impairment
14. Metabolism pathway of vinorelbine (Navelbine®) in human: Characterisation of the metabolites by HPLC–MS/MS
15. Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumours
16. Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors
17. Les essais cliniques en cancérologie pédiatrique
18. Clinical Trials in Paediatric Oncology
19. P-Glycoprotein Activity in an in Vitro Blood-Brain Barrier Model
20. New sensitive liquid chromatography method coupled with tandem mass spectrometric detection for the clinical analysis of vinorelbine and its metabolites in blood, plasma, urine and faeces
21. Monoamine uptake inhibition by plasma from healthy volunteers after single oral doses of the antidepressant milnacipran
22. Influence on Busilvex (R) Pharmacokinetics of Clonazepam Compared to Previous Phenytoin Historical Data
23. Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer
24. Metronomic Oral Vinorelbine in Patients with Recurrent Breast, Prostate or Non-Small Cell Lung Cancer: Optimal Dose-Finding Trial of the Hellenic Cooperative Oncology Group
25. Phase I and pharmacokinetic (PK) dose-adjusted study of IV vinflunine (VFL) in cancer patients with liver dysfunction (LD): Pharmacokinetic results
26. Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring
27. 109 POSTER Metronomic oral vinorelbine: dose escalation study, pharmacokinetics and assessment of predictive biomarkers
28. Intravenous busulfan in adults prior to haematopoietic stem cell transplantation: a population pharmacokinetic study
29. A new IV busulfan fixed dosing for better exposure targeting in children undergoing allogeneic or autologous hematopoietic stem cell transplantation
30. P.1.011 Absence of interaction of milnacipran with the cytochrome P450 system — evidence from human volunteer studies
31. Determination of milnacipran, a serotonin and noradrenaline reuptake inhibitor, in human plasma using liquid chromatography with spectrofluorimetric detection
32. 560 Search for drug-drug interaction between oral vinorelbine (VRL) and capecitabine (CAP) in metastatic breast cancer (MBC) during a dose finding study
33. Clinical Trials in Paediatric Oncology
34. Les essais cliniques en cancérologie pédiatrique
35. Reliable use of Navelbine oral based on pharmacokinetic (PK) bioequivalence
36. Validated method for the determination of idazoxan in human plasma by liquid chromatography with tandem mass spectrometric detection
37. Pharmacokinetics of milnacipran in comparison with other antidepressants
38. Selective drug transport and P-glycoprotein activity in an in vitro blood-brain barrier model
39. Acute electrophysiological effects of intravenous milnacipran, a new antidepressant agent
40. Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat
41. Phase I/II and pharmacokinetic study of intravenous vinflunine in combination with cisplatin for the treatment of chemonaive patients with advanced non-small-cell lung cancer.
42. New sensitive liquid chromatography method coupled with tandem mass spectrometric detection for the clinical analysis of vinorelbine and its metabolites in blood, plasma, urine and faeces
43. Validated method for the determination of idazoxan in human plasma by liquid chromatography with tandem mass spectrometric detection
44. Influence on Busilvex® pharmacokinetics of clonazepam compared to previous phenytoin historical data
45. Differences in the metabolism of epicainide in rats and man
46. Comparative study of binding of an antiallergic substance to serum albumin and erythrocytes in man, in the dog and in the rat
47. Differences in the metabolism of epicainide in rats and man
48. Metabolism pathway of vinorelbine (Navelbine®) in human: Characterisation of the metabolites by HPLC–MS/MS
49. Oral vinorelbine in the treatment of non-small cell lung cancer: rationale and implications for patient management
50. Oral versus intravenous vinorelbine: clinical safety profile
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.